People · Operator
Named in public records as an officer, director or promoter · active 2010–2014 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| PaxVax Inc | — | Pharmaceuticals | Series B | $127.6M | $204.0M | 2010 |
Phil B. Russell at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Phil B. Russell on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Howard B. Rosen | 1 | 4 |
| Kenneth J. Kelley | 1 | 3 |
| Henry G. Coit, Jr. | 1 | 1 |
| Richard B. Tong | 1 | 1 |
| JAMES B. CONNOLLY | 1 | 1 |
| Janine M. Taylor | 1 | 1 |
| Rennie J. Coit | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.